A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

NCT04657016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

579

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Tirzepatide
OTHER: Placebo

Sponsor

Eli Lilly and Company